The first-phase project has a total investment of 120 million yuan. Upon completion, it will include: - A synthesis workshop equipped with a 3-ton/year Vitamin D2 production line and a 3-ton/year Vitamin D3 production line. - A comprehensive extraction workshop featuring: - One standardized Scutellaria baicalensis glycoside (Baicalin) production line with an annual capacity of 80 tons; - One 150-ton/year berberine hydrochloride production line; - One 80-ton/year rutin production line; - One 10-ton/year andrographolide production line; - One 10-ton/year puerarin production line; - One 50,000-ton/year traditional Chinese medicine granule production line, including specific lines for: - Phellodendron bark granules (8,000 tons/year); - Scutellaria root granules (12,000 tons/year); - Sophora japonica flower buds granules (4,000 tons/year); - Pueraria root granules (9,000 tons/year); - Ginkgo leaf granules (3,000 tons/year); - Honeysuckle flower granules (4,000 tons/year); - Forsythia fruit granules (5,000 tons/year); - Andrographis paniculata granules (5,000 tons/year). All production lines are designed as standardized facilities that fully comply with GMP requirements.
Phase One Project
2025-10-24
Project Overview: Multi-functional Extraction Production Line Design Capacity: 6 tons/year for chemical synthesis, 400 tons/year for extraction, and 50,000 units/year for processed herbal medicines. Projected Output Value: 500 million
undefined